Zacks Investment Research

Filter by Popularity: - - - -
Warren Buffett's bullishness, opportunities for value investors and Trump's deregulatory measures are expected to boost America's banking industry in 2019. [Read More]
Steel Dynamics (STLD) expects earnings for Q1 in the band of 88-92 cents per share, lower than 96 cents per share it earned a year... [Read More]
Skechers' (SKX) greater emphasis on new line of products, store remodeling projects, cost containment efforts, inventory management, and global distribution platform are impressive. [Read More]
Stocks with a rich tradition of dividend payout leads to a healthy portfolio and carry tax advantages... [Read More]
Industrial production recorded positive growth in February against a contraction in January. C... [Read More]
The Fed is expected to reduce expectations for future rate hikes and announce when and how it plans to end balance sheet reductions. [Read More]
Markets closed in the green on Monday ahead of Federal Reserve's two-day policy meeting. [Read More]
Dana (DAN) introduces differential for Spicer S140 single drive axles for use in Class 6 applications. [Read More]
Cousins Properties (CUZ) stellar revenue and earnings growth prospects, along with efforts to improve portfolio through strategic buyouts, make it an investment-worthy stock. [Read More]
Catalyst (CPRX) reports wider-than-expected loss in the fourth quarter of 2018. [Read More]
Transocean (RIG) secured contracts for two of its drillships, namely Mykonos and Corcovado, which were acquired as part of Ocean Rig buyout in December 2018. [Read More]
Shares in late trading fell on the news of an earnings miss and lowered guidance; the stock is currently down more that 4% in late... [Read More]
Abiomed (ABMD) closed the most recent trading day at $339.28, moving +1.81% from the previous trading session. [Read More]
Citigroup (C) closed at $65.63 in the latest trading session, marking a -0.46% move from the prior day. [Read More]
In the latest trading session, Chesapeake Energy (CHK) closed at $3.16, marking a +0.32% move from the previous day. [Read More]
Puma Biotech (PBYI) gains an approval in Australia for Nerlynx as an extended adjuvant treatment in adult patients with early stage HER2-positive breast cancer. [Read More]
In the latest trading session, Spirit (SAVE) closed at $53.70, marking a +1.61% move from the previous day. [Read More]
The expanded deal enables Univar (UNVR) to boost its offering for the beauty and personal care market. [Read More]
Apple's (AAPL) much-anticipated video streaming service, set to launch on Mar 25, will not include Netflix's streaming platform. [Read More]
Phibro Animal (PAHC) has been gaining from strong volume growth in foreign markets. However, adverse currency movements remain a concern. [Read More]
Jump To: